Martha R Kelso

ORCID: 0000-0002-5976-6938
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Wound Healing and Treatments
  • Diabetic Foot Ulcer Assessment and Management
  • Pressure Ulcer Prevention and Management
  • Diagnosis and Treatment of Venous Diseases
  • Surgical site infection prevention
  • Orthopedic Infections and Treatments
  • Balance, Gait, and Falls Prevention
  • Venous Thromboembolism Diagnosis and Management

Wound Care Strategies (United States)
2021-2025

To evaluate the cost-effectiveness and budget impact of using standard care (no advanced treatment, NAT) compared with an treatment (AT), dehydrated human amnion/chorion membrane (DHACM), when following parameters for use (FPFU) in treating lower extremity diabetic ulcers (LEDUs).We analysed a retrospective cohort Medicare patients (2015-2019) to generate four propensity-matched cohorts LEDU episodes. Outcomes DHACM NAT, such as amputations, healthcare utilisation were tracked from claims...

10.12968/jowc.2022.31.sup2.s10 article EN Journal of Wound Care 2022-02-01

Underrepresentation of diverse skin tones in medical education and providers' implicit racial bias drives inequities wound care, such as disproportionally poor outcomes for Black patients. Diagnostic indicators (e.g., erythema) can present differently depending on pigmentation. This post hoc analysis 350 chronic wounds from a prospective 14-site clinical trial aimed to determine how the perception signs symptoms infection (CSS) differs by patient tone if fluorescence-imaging offer more...

10.1007/s40615-023-01584-8 article EN cc-by Journal of Racial and Ethnic Health Disparities 2023-04-11

Objective: To evaluate the cost-effectiveness of dehydrated human amnion/chorion membrane (DHACM) in Medicare enrolees who developed a venous leg ulcer (VLU). Method: This economic evaluation used four-state Markov model to simulate disease progression VLUs for patients receiving advanced treatment (AT) with DHACM or no (NAT) over three-year time horizon from US perspective. treatments were assessed when following parameters use (FPFU), whereby applications initiated 30–45 days after initial...

10.12968/jowc.2024.33.sup3.s24 article EN Journal of Wound Care 2024-03-01

Objective: To evaluate large propensity-matched cohorts to assess outcomes in patients receiving advanced treatment (AT) with skin substitutes for lower extremity diabetic ulcers (LEDUs) versus no AT (NAT) the management of LEDUs. Method: The Medicare Limited Dataset (1 October 2015 through 2 2018) were used retrospectively analyse people care a LEDU treated or NAT (propensity-matched Group 1). Analysis included major and minor amputations, emergency department (ED) visits hospital...

10.12968/jowc.2021.30.sup7.s5 article EN Journal of Wound Care 2021-07-01

Journal of Wound CareEarly view Roundtable ReportFree AccessAn advanced diagnostic imaging tool to enhance clinical decision-making and wound healingThomas Serena, William H Tettelbach, Andrew Rader, Amy Couch, Naz Wahab, Misael Alonso, Dan Kapp, Martha Kelso, Martin L Johnson, Marcus GitterleThomas SerenaCorresponding author email: E-mail Address: [email protected]MD, FACS, FACHM, MAPWCA, CEO Medical Director SerenaGroup Inc. Research Foundation, US, TettelbachMD, FACP, FIDSA, FUHM, Chief...

10.12968/jowc.2025.0104 article EN Journal of Wound Care 2025-03-22

Objective: To evaluate the impact of Medicare’s future effective Local Coverage Determination (LCD) for cellular, acellular and matrix-like products (CAMPs), which, while informed by a literature review expert input, was finalised without incorporating detailed statistical or cost analysis its projected clinical economic across diverse wound care delivery settings (e.g., hospital-affiliated, private practice, post-acute care). This focuses on consequences Medicare beneficiaries with chronic...

10.12968/jowc.2025.0120 article EN Journal of Wound Care 2025-04-08

Excessive levels of bacteria impede wound healing and can lead to infectious complications. Unfortunately, clinical signs symptoms elevated bacterial burden are often unreliable. As a result, point--of--care fluorescence imaging, used detect critical in wounds, is becoming widely recognized adopted by clinicians across the globe as an accepted added component assessment protocol. A Delphi method was employed establish consensus guidelines describing imaging use. multidisciplinary panel 32...

10.3390/diagnostics11071219 article EN cc-by Diagnostics 2021-07-06

To retrospectively evaluate the comorbidities, treatment patterns and outcomes of Medicare enrolees who developed venous leg ulcers (VLUs).Medicare Limited Data Standard Analytic Hospital Inpatient Outpatient Department Files were used to follow patients received medical care for a VLU between 1 October 2015 2 2019. Patients diagnosed with chronic insufficiency (CVI) propensity matched into four groups based on their regimen. Episode claims document demographics, comorbidities treatments...

10.12968/jowc.2023.32.11.704 article EN Journal of Wound Care 2023-11-01

High bacterial burden stalls wound healing and can quickly progress to infection sepsis in complex, older-adult patients long-term care (LTC) or skilled nursing facilities (SNFs).

10.1097/asw.0000000000000177 article EN Advances in Skin & Wound Care 2024-07-17

Objective: To quantify race, sex, comorbidities, Medicaid status, and compare health outcomes for Medicare-only versus Medicare/Medicaid dual-enrolees who developed a hard-to-heal venous leg ulcer (VLU). Method: Medicare Limited Data Standard analytic hospital inpatient outpatient department files were used to follow episodes of medical care VLU from 1 October 2015–2 2019. In an earlier study, patients diagnosed concurrently with chronic insufficiency propensity-matched. this current work,...

10.12968/jowc.2024.0174 article EN Journal of Wound Care 2024-11-23
Coming Soon ...